A simple algebraic approximation to the Erlang loss systemADELMAN, Daniel.Operations research letters. 2008, Vol 36, Num 4, pp 484-491, issn 0167-6377, 8 p.Article

Price-Directed Control of a Closed Logistics Queueing NetworkADELMAN, Daniel.Operations research. 2007, Vol 55, Num 6, pp 1022-1038, issn 0030-364X, 17 p.Article

Dynamic bid prices in revenue managementADELMAN, Daniel.Operations research. 2007, Vol 55, Num 4, pp 647-661, issn 0030-364X, 15 p.Article

Existence of optimal policies for semi-Markov decision processes using duality for infinite linear programmingKLABJAN, Diego; ADELMAN, Daniel.SIAM journal on control and optimization. 2006, Vol 44, Num 6, pp 2104-2122, issn 0363-0129, 19 p.Article

An Approximate Dynamic Programming Approach to Network Revenue Management with Customer ChoiceDAN ZHANG; ADELMAN, Daniel.Transportation science. 2009, Vol 43, Num 3, pp 381-394, issn 0041-1655, 14 p.Article

Relaxations of Weakly Coupled Stochastic Dynamic ProgramsADELMAN, Daniel; MERSEREAU, Adam J.Operations research. 2008, Vol 56, Num 3, pp 712-727, issn 0030-364X, 16 p.Article

Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapyCORREN, Jonathan; SHAPIRO, Gail; REIMANN, James et al.Journal of allergy and clinical immunology. 2008, Vol 121, Num 2, pp 506-511, issn 0091-6749, 6 p.Article

Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesisCORREN, Jonathan; DIAZ-SANCHEZ, David; SAXON, Andrew et al.Annals of allergy, asthma, & immunology. 2004, Vol 93, Num 3, pp 243-248, issn 1081-1206, 6 p.Article

Photodynamic therapy with motexafin lutetium induces redox-sensitive apoptosis of vascular cellsZHIPING CHEN; WOODBURN, Kathryn W; CAN SHI et al.Arteriosclerosis, thrombosis, and vascular biology. 2001, Vol 21, Num 5, pp 759-764, issn 1079-5642Article

Photodynamic therapy: Applications in atherosclerotic vascular disease with motexafin lutetiumCHOU, Tony M; WOODBURN, Kathryn W; CHEONG, Wai-Fung et al.Catheterization and cardiovascular interventions. 2002, Vol 57, Num 3, pp 387-394, issn 1522-1946, 8 p.Article

Photoangioplasty for human peripheral atherosclerosis: Results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin)ROCKSON, Stanley G; KRAMER, Paul; ADELMAN, Daniel C et al.Circulation (New York, N.Y.). 2000, Vol 102, Num 19, pp 2322-2324, issn 0009-7322Article

Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: Procedural and long-term resultsKEREIAKES, Dean J; SZYNISZEWSKI, Arthur M; CHOU, Tony M et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 11, pp 1310-1315, issn 0009-7322, 6 p.Article

Voreloxin, a First-in-Class Anticancer Quinolone Derivative, in Relapsed/Refractory Solid Tumors: A Report on Two Dosing SchedulesADVANI, Ranjana H; HURWITZ, Herbert I; FOX, Judith A et al.Clinical cancer research (Print). 2010, Vol 16, Num 7, pp 2167-2175, issn 1078-0432, 9 p.Article